NABsys Buys Hybridization Company GeneSpectrum to Pursue $1,000 Genome | GenomeWeb
NEW YORK (GenomeWeb News) - NABsys, a next-generation sequencing company based in Providence, RI, said today that it has purchased DNA hybridization company GeneSpectrum in an all-stock transaction.
 
NABsys said it will combine GeneSpectrum's probe design and hybridization techniques with its nanopore-based technology, which it has licensed from Brown University, to sequence human DNA at dramatically cheaper rates.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.